References
- Cucinotta D , VanelliM. WHO declares COVID-19 a pandemic. Acta Biomed.91(1), 157–160 (2020).
- Lewis MA . Between Scylla and Charybdis - oncologic decision making in the time of Covid-19. N. Engl. J. Med.382(24), 2285–2287 (2020).
- Kotru S , KlimuntowskiM, RidhaHet al. Electrochemical sensing: a prognostic tool in the fight against COVID-19. Trends Analyt. Chem.136, 116198 (2021).
- Commissioner O of the . Pfizer-BioNTech COVID-19 Vaccine. FDA, (2021). https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine.
- Commissioner O of the . Moderna COVID-19 Vaccine. FDA, (2021). https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine.
- Polack FP , ThomasSJ, KitchinNet al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med.383(27), 2603–2615 (2020).
- Baden LR , ElSahly HM, EssinkBet al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. [Internet]. (2020). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787219/
- Sahin U , MuikA, DerhovanessianEet al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature586(7830), 594–599 (2020).
- Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines | CDC [Internet]. (2021). https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html
- COVID-19 Vaccine & Patients with Cancer [Internet]. ASCO (2020). https://www.asco.org/asco-coronavirus-resources/covid-19-patient-care-information/covid-19-vaccine-patients-cancer-information/covid-19-vaccine-patients-cancer
- European Society for Medical Oncology . ESMO Call to Action on COVID-19 Vaccinations and Patients with Cancer: vaccinate. Monitor. Educate. [Internet] Available from: https://www.esmo.org/policy/esmo-call-to-action-on-covid-19-vaccinations-and-patients-with-cancer-vaccinate-monitor-educate
- NCCN Releases Initial Guidance for COVID-19 Vaccine Administration in Patients with Cancer [Internet]. Cancer Network. https://www.cancernetwork.com/view/nccn-releases-initial-guidance-for-covid-19-vaccine-administration-in-patients-with-cancer
- Harrison EA , WuJW. Vaccine confidence in the time of COVID-19. Eur. J. Epidemiol.35(4), 325–330 (2020).
- Coustasse A , KimbleC, MaxikK. COVID-19 and vaccine hesitancy: a challenge the United States must overcome. J. Ambul. Care Manage.44(1), 71–75 (2021).
- Lin Y , HuZ, ZhaoQ, AliasH, DanaeeM, WongLP. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl. Trop. Dis. [Internet].14(12), (2020). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775119/.
- Barello S , NaniaT, DellafioreF, GraffignaG, CarusoR. ‘Vaccine hesitancy’ among university students in Italy during the COVID-19 pandemic. Eur. J. Epidemiol.35, 781–783 (2020).
- A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect. Dis.20(7), 769–770 (2020).
- Reiter PL , PennellML, KatzML. Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated?Vaccine38(42), 6500–6507 (2020).
- Fisher KA , BloomstoneSJ, WalderJ, CrawfordS, FouayziH, MazorKM. Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults. Ann. Intern. Med. [Internet]. (2020). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505019/.
- Guidry JPD , LaestadiusLI, VragaEKet al. Willingness to get the COVID-19 vaccine with and without emergency use authorization. Am. J. Infect. Control49(2), 137–142 (2021).
- Abdelhafiz AS , MohammedZ, IbrahimMEet al. Knowledge, perceptions, and attitude of Egyptians towards the novel Coronavirus disease (COVID-19). J. Community Health.45(5), 881–890 (2020).
- Kattan C , BadreddineH, RassyE, KourieHR, KattanJ. The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience. Future Oncol.16(17), 1157–1160 (2020).
- Ribas A , SenguptaR, LockeTet al. Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited. Cancer Discov.11(2), 233–236 (2021).